Nevertheless, some studies suggested that subgroups of sepsis patients with excessive inflammation may benefit from immunosuppressive therapy, such as IL-1 receptor blockade or anti-TNF neutralizing antibody (41). The gene discussed is TNF; the disease is Sepsis.